These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31190154)

  • 61. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adherence to European Association of Urology Guidelines on Prophylactic Antibiotics: An Important Step in Antimicrobial Stewardship.
    Cai T; Verze P; Brugnolli A; Tiscione D; Luciani LG; Eccher C; Lanzafame P; Malossini G; Wagenlehner FM; Mirone V; Bjerklund Johansen TE; Pickard R; Bartoletti R
    Eur Urol; 2016 Feb; 69(2):276-83. PubMed ID: 26001610
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Utilizing a Questionnaire to Implement a Risk-based Antibiotic Prophylaxis Protocol for Transrectal Prostate Biopsy.
    Gul ZG; Yu M; Sharbaugh DR; Pekala KR; Lin JY; Sharbaugh AJ; Zhu TS; Worku H; Armann KM; Hudson CN; Hay JM; Grajales V; Yabes JG; Davies BJ; Jacobs BL
    Urology; 2023 May; 175():18-24. PubMed ID: 36868411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nonantibiotic Strategies for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Pradere B; Veeratterapillay R; Dimitropoulos K; Yuan Y; Omar MI; MacLennan S; Cai T; Bruyère F; Bartoletti R; Köves B; Wagenlehner F; Bonkat G; Pilatz A
    J Urol; 2021 Mar; 205(3):653-663. PubMed ID: 33026903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prospective Feasibility Study of Single-Shot Antibiotic Prophylaxis in Transrectal Focal Ablation of Prostate Cancer.
    Westhoff N; Ritter M; Maros M; Rassweiler-Seyfried MC; Michel MS; Honeck P; von Hardenberg J
    Urol Int; 2020; 104(5-6):378-385. PubMed ID: 32396911
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
    Krsakova E; Cermak A; Fedorko M
    J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.
    Loeb S; van den Heuvel S; Zhu X; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2012 Jun; 61(6):1110-4. PubMed ID: 22244150
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibiotic prophylaxis for elective hysterectomy.
    Ayeleke RO; Mourad S; Marjoribanks J; Calis KA; Jordan V
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD004637. PubMed ID: 28625021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. AUA Quality Improvement Summit 2014: Conference Proceedings on Infectious Complications of Transrectal Prostate Needle Biopsy.
    Averch T; Tessier C; Clemens JQ; Franks M; Gonzalez C; Jones JS; Kapoor DA; Lightner DJ; Liss M; Montie J; Watson RA; Wolf JS
    Urol Pract; 2015 Jul; 2(4):172-180. PubMed ID: 37559293
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
    Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
    J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.
    Tan WP; Papagiannopoulos D; Latchamsetty KC; Wilson N; O'Block N; Raff L; Mena Lora A; Coogan CL; Abern MR
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):268-275. PubMed ID: 30279581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Routine Ertapenem Prophylaxis for Transrectal Ultrasound Guided Prostate Biopsy does Not Select for Carbapenem Resistant Organisms: A Prospective Cohort Study.
    Bloomfield MG; Page MJ; McLachlan AG; Studd RC; Blackmore TK
    J Urol; 2017 Aug; 198(2):362-368. PubMed ID: 28288838
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized controlled trial of antibiotic prophylaxis regimens for transrectal ultrasound-guided prostate biopsy.
    Chan ES; Lo KL; Ng CF; Hou SM; Yip SK
    Chin Med J (Engl); 2012 Jul; 125(14):2432-5. PubMed ID: 22882916
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy.
    Wenzel M; Welte MN; Theissen LH; Wittler C; Hoeh B; Humke C; Preisser F; Würnschimmel C; Tilki D; Graefen M; Roos FC; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Mandel P
    Eur Urol Focus; 2021 Sep; 7(5):980-986. PubMed ID: 33358884
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Importance of Antibiotic Regimen in Transrectal Ultrasound-Guided Prostate Biopsy: A Single Center Analysis of Nine Thousand Four Hundred Eighty-Seven Cases.
    Seo YE; Ryu H; Oh JJ; Jeong SJ; Hwang SI; Lee HJ; Hong SK; Byun SS; Lee SE; Lee S
    Surg Infect (Larchmt); 2018 Oct; 19(7):704-710. PubMed ID: 30227106
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy?
    Tuncel A; Aslan Y; Sezgin T; Aydin O; Tekdogan U; Atan A
    Urology; 2008 Jun; 71(6):1024-7; discussion 1027-8. PubMed ID: 18400273
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antibiotic prophylaxis and complications following prostate biopsies - a systematic review.
    Klemann N; Helgstrand JT; Brasso K; Vainer B; Iversen P; Røder MA
    Dan Med J; 2017 Jan; 64(1):. PubMed ID: 28007054
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
    Shigemura K; Yasufuku T; Yamashita M; Arakawa S; Fujisawa M
    Int J Urol; 2009 Sep; 16(9):723-5. PubMed ID: 19638042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.